Skip to main content
News Directory 3
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Iron Dysregulation & Ferroptosis: Pulmonary Fibrosis Targets

Iron Dysregulation & Ferroptosis: Pulmonary Fibrosis Targets

August 30, 2025 Dr. Jennifer Chen Health

ferroptosis: ⁢A Potential New Target for Pulmonary Fibrosis Treatment

Pulmonary fibrosis (PF) is a severe lung disease with a poor‌ prognosis, currently ​managed ‍with treatments that only slow progression, ⁣and lung transplantation as the only definitive option. Though,​ research is increasingly focusing on ferroptosis – a regulated, ‌iron-dependent form of cell death – as a key driver of PF development and ⁤a potential therapeutic target.Here’s a breakdown of the key points:

What⁤ is Ferroptosis? It’s a type of programmed‍ cell death caused by⁤ iron-dependent ⁣lipid peroxidation, leading to oxidative ​damage to cell membranes. It differs⁤ from apoptosis.
Why is⁢ it relevant to PF? Oxidative⁢ stress and iron overload in the lungs trigger ferroptosis in crucial​ lung cells (alveolar epithelial cells, macrophages, and fibroblasts), contributing to scarring and fibrosis.
Evidence ‍supporting the link:
Research shows ferroptosis contributes to macrophage polarization, fibroblast ⁤proliferation, ECM deposition, and ultimately, alveolar cell death.
Animal studies demonstrate that iron chelators and ferroptosis inhibitors can reduce‌ fibrosis by protecting epithelial cells,‌ suppressing​ inflammation, and limiting ⁢fibroblast activation. How it affects different lung cells:
Alveolar Epithelial Cells (aecs): Iron overload weakens their ability to repair damage, and their ferroptosis promotes⁤ abnormal healing and fibrosis. Drugs⁤ like ‌deferoxamine⁤ and liproxstatin-1 show promise ‌in protecting AECs. Alveolar Macrophages (AMs): Iron-laden macrophages accumulate in fibrotic lungs ‍and release factors that promote fibrosis.
Broader Implications: Ferroptosis appears to be a ⁢common​ mechanism in fibrotic diseases affecting the ⁢lungs, liver, ‍and kidneys, suggesting ⁣potential for therapies⁤ developed for PF to have wider applications.

In essence, targeting ferroptosis pathways ‌coudl offer⁤ a new approach to treating PF, possibly halting or even reversing the disease process.

Sources:

  1. ⁣ Review published in ⁤ Molecules and Cells*: https://www.sciencedirect.com/science/article/pii/S1016847825000883
  2. Previous research: https://pubmed.ncbi.nlm.nih.gov/38914560/

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

pulmonary fibrosis, pulmonary fibrosis progression, targets in pulmonary fibrosis

Search:

News Directory 3

ByoDirectory is a comprehensive directory of businesses and services across the United States. Find what you need, when you need it.

Quick Links

  • Copyright Notice
  • Disclaimer
  • Terms and Conditions

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

Connect With Us

© 2026 News Directory 3. All rights reserved.

Privacy Policy Terms of Service